IQVIA stock rises amid $2 billion senior notes offering

IQVIA Holdings Inc. (NYSE:IQV) saw its shares climb 4.3% in post-market trading Wednesday, after the company said its subsidiary had priced a $2 billion senior notes offering maturing in 2034.

The notes, issued through wholly owned subsidiary IQVIA Inc., carry a 6.375% annual coupon with semi-annual interest payments starting March 15, 2027. The debt will come due on March 15, 2034.

IQVIA said the offering's proceeds will go toward fully redeeming its existing 5.000% Senior Notes due 2026, paying down a portion of borrowings outstanding under its revolving credit facility, and covering fees and expenses tied to the notes offering.

The issuance is expected to close on or about September 23, 2026, subject to customary closing conditions. The notes are being marketed to qualified institutional buyers in the U.S. under Rule 144A and to non-U.S. investors outside the United States under Regulation S of the Securities Act of 1933.

IQVIA provides clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies worldwide. The firm operates in more than 100 countries and employs about 94,000 people.

This article was produced with the assistance of AI and reviewed by an editor. For additional details, please refer to our terms and conditions.